These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 315976)

  • 21. Interaction of methotrexate and betamethasone with experimental phototoxic inflammation to PUVA (Psoralen and UVA) in mice.
    Ljunggren B; Möller H
    Arch Dermatol Res; 1979 Mar; 264(2):257-60. PubMed ID: 464643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue anoxia prevents inflammation and pigmentation caused by UVA but not by UVB or PUVA.
    Tegner E
    Photodermatol; 1984 Dec; 1(6):311-2. PubMed ID: 6533624
    [No Abstract]   [Full Text] [Related]  

  • 23. Ultraviolet radiation-induced inflammation and leukocytes.
    Eaglstein WH; Sakai M; Mizuno N
    J Invest Dermatol; 1979 Feb; 72(2):59-63. PubMed ID: 422868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cutaneous hypoxia upon erythema and pigment responses to UVA, UVB, and PUVA (8-MOP + UVA) in human skin.
    Auletta M; Gange RW; Tan OT; Matzinger E
    J Invest Dermatol; 1986 Jun; 86(6):649-52. PubMed ID: 3711678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous phototoxicity due to psoralens.
    Gange RW; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():117-26. PubMed ID: 6531018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
    Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
    Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unscheduled DNA synthesis in normal human skin after single and combined doses of UV-A, UV-B and UV-A with methoxsalen (PUVA).
    Hönigsmann H; Jaenicke KF; Brenner W; Rauschmeier W; Parrish JA
    Br J Dermatol; 1981 Nov; 105(5):491-501. PubMed ID: 7295566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects.
    Lowe NJ; Dromgoole SH; Sefton J; Bourget T; Weingarten D
    J Am Acad Dermatol; 1987 Aug; 17(2 Pt 1):224-30. PubMed ID: 3624560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythema resulting from suberythemogenic doses of ultraviolet radiation and methotrexate.
    LeVine MJ
    Arch Dermatol; 1981 Oct; 117(10):656-8. PubMed ID: 7283458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photocarcinogenicity of psoralens used in PUVA treatment: present status in mouse and man.
    Young AR
    J Photochem Photobiol B; 1990 Jun; 6(1-2):237-47. PubMed ID: 2121937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of psoralen and UVA (PUVA) on epidermal melanocytes of the tail in C57BL mice.
    Blog FB; Szabo G
    J Invest Dermatol; 1979 Dec; 73(6):533-7. PubMed ID: 512405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PUVA, pruritus, and the loss of the axon flare.
    Jordan WP
    Arch Dermatol; 1979 May; 115(5):636. PubMed ID: 443845
    [No Abstract]   [Full Text] [Related]  

  • 35. [Could PUVA therapy and solar lights provoke ocular lesions?].
    De Witte E; Coppens A; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 185():111-7. PubMed ID: 540187
    [No Abstract]   [Full Text] [Related]  

  • 36. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time.
    Meffert H; Andersen KE; Sönnichsen N
    Photodermatol; 1984 Aug; 1(4):191-4. PubMed ID: 6531293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group.
    Halpern SM; Anstey AV; Dawe RS; Diffey BL; Farr PM; Ferguson J; Hawk JL; Ibbotson S; McGregor JM; Murphy GM; Thomas SE; Rhodes LE
    Br J Dermatol; 2000 Jan; 142(1):22-31. PubMed ID: 10651690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the immunologic reactivity of mice treated with UVB or methoxsalen plus UVA radiation.
    Kripke ML; Morison WL; Parrish JA
    J Invest Dermatol; 1981 Jun; 76(6):445-8. PubMed ID: 6453906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of PUVA and UVB radiation on delayed hypersensitivity in the guinea pig.
    Morison WL; Parrish JA; Woehler ME; Krugler JI; Bloch KJ
    J Invest Dermatol; 1981 Jun; 76(6):484-8. PubMed ID: 6165782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    Takashima A; Yamamoto K; Kimura S; Takakuwa Y; Mizuno N
    Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.